Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Diasoft reported for 9 months of 2024 by RAS

10/22/24 DIAS

Magnit opened the first Magnet Go in the Moscow subway

10/22/24 MGNT

Yandex.Fabrika presented its first brand of basic clothing

10/22/24 YDEX

T-Investments will launch trading in digital financial assets

10/22/24 T

NKHP reported for 9 months of 2024 by RAS

10/22/24 NKHP

Izhstal reported for 9 months of 2024 by RAS

10/22/24 IGST

Seligdar reduced gold production by 5%

10/22/24 SELG

TGC-1 increased energy generation by 9%

10/22/24 TGKA

Softline's Board of Directors approved the buyback

10/22/24 SOFL

Board of Directors of Whoosh recommended dividends

10/22/24 WUSH